In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

Bioluminescent RNA lanterns have revolutionized the way researchers track RNA activity within living organisms. In a groundbreaking study, scientists at the University of California, Irvine (UCI) ...

Researchers from Cleveland Clinic's Genome Center have outlined the pathway human herpes simplex virus-1 (HSV1) can use to ...

Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and ...

Maravai LifeSciences Inc., a provider of life science reagents and services to researchers and biotech innovators, has ...

Famed chip maker and hardware giant Nvidia has been investing significant resources into the healthcare and life sciences ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

At the cellular level, pieces of important genetic information, called small RNA, have the ability to introduce important ...